F. Fei, J. Qu, M. Zhang, Y. Li, and S. Zhang, S100A4 in cancer progression and metastasis: A systematic review, Oncotarget, vol.8, pp.73219-73239, 2017.

Y. Liu and X. Cao, Characteristics and significance of the pre-metastatic niche, Cancer Cell, vol.30, pp.668-681, 2016.

M. T. Hansen, B. Forst, N. Cremers, L. Quagliata, N. Ambartsumian et al., A link between inflammation and metastasis: Serum amyloid A1 and A3 induce metastasis, and are targets of metastasis-inducing S100A4, Oncogene, vol.34, pp.424-435, 2015.

C. L. Chaffer, B. P. San-juan, E. Lim, and R. A. Weinberg, EMT, cell plasticity and metastasis, Cancer Metastasis Rev, vol.35, pp.645-654, 2016.

A. Pezzuto and E. Carico, Role of HIF-1 in cancer progression: Novel insights. A review, Curr. Mol. Med, vol.18, pp.343-351, 2018.

A. R. Bresnick, D. J. Weber, and D. B. Zimmer, S100 proteins in cancer, Nat. Rev. Cancer, vol.15, pp.96-109, 2015.

M. D. Amatangelo, S. Goodyear, D. Varma, and M. E. Stearns, C-Myc expression and MEK1-induced Erk2 nuclear localization are required for TGF-beta induced epithelial-mesenchymal transition and invasion in prostate cancer, Carcinogenesis, vol.33, 1965.

M. Liu, J. Liu, B. Yang, X. Gao, L. L. Gao et al., Inversed expression patterns of S100A4 and E-cadherin in cervical cancers: Implication in epithelial-mesenchymal transition, Anat. Rec, vol.300, pp.2184-2191, 2017.

K. Chow, H. J. Park, J. George, K. Yamamoto, A. D. Gallup et al., S100A4 is a biomarker and regulator of glioma stem cells that is critical for mesenchymal transition in glioblastoma, Cancer Res, vol.77, pp.5360-5373, 2017.

K. Weidenfeld and D. Barkan, EMT and stemness in tumor dormancy and outgrowth: Are they intertwined processes?, Front. Oncol, vol.8, p.381, 2018.

S. Klebe, N. A. Brownlee, A. Mahar, J. L. Burchette, T. A. Sporn et al., Sarcomatoid mesothelioma: A clinical-pathological correlation of 326 cases, Mod. Pathol, vol.23, pp.470-479, 2010.

G. Pinton, A. G. Manente, D. Tavian, L. Moro, and L. Mutti, Therapies currently in phase II trials for malignant pleural mesothelioma, Exp. Opin. Investig. Drugs, vol.22, pp.1255-1263, 2013.

J. Minnema-luiting, H. Vroman, J. Aerts, and R. Cornelissen, Heterogeneity in immune cell content in malignant pleural mesothelioma, Int. J. Mol. Sci, 1041.

M. A. Bonelli, C. Fumarola, S. La-monica, and R. Alfieri, New therapeutic strategies for malignant pleural mesothelioma, Biochem. Pharmacol, vol.123, pp.8-18, 2017.

A. M. Marchevsky, Application of immunohistochemistry to the diagnosis of malignant mesothelioma, Arch. Pathol. Lab. Med, vol.132, pp.397-401, 2008.

Z. Chen, G. Gaudino, H. I. Pass, M. Carbone, and H. Yang, Diagnostic and prognostic biomarkers for malignant mesothelioma: An update, Trans. Lung Cancer Res, vol.6, pp.259-269, 2017.

J. S. Nader, J. Abadie, S. Deshayes, A. Boissard, S. Blandin et al., Characterization of increasing stages of invasiveness identifies stromal/cancer cell crosstalk in rat models of mesothelioma, Oncotarget, vol.9, pp.16311-16329, 2018.
URL : https://hal.archives-ouvertes.fr/inserm-01726393

D. Roulois, S. Deshayes, M. Guilly, J. S. Nader, C. Liddell et al., Characterization of preneoplastic and neoplastic rat mesothelial cell lines: The involvement of TETs, DNMTs, and 5-hydroxymethylcytosine, Oncotarget, vol.7, pp.34664-34687, 2016.
URL : https://hal.archives-ouvertes.fr/inserm-01306838

M. J. Hoenerhoff, H. H. Hong, T. Ton, S. A. Lahousse, and R. C. Sills, A review of the molecular mechanisms of chemically-induced neoplasia in rat and mouse models in National Toxicology Program bioassays and their relevance to human cancer, Toxicol. Pathol, vol.37, pp.835-848, 2009.

M. J. Van-nimwegen, S. Verkoeijen, P. J. Kuppen, J. H. Velthuis, and B. Van-de-water, An improved method to study NK-independent mechanisms of MTLn3 breast cancer lung metastasis, Clin. Exp. Metastasis, vol.24, pp.379-387, 2007.

A. Liao, K. Broeg, T. Fox, S. Tan, R. Watters et al., Therapeutic efficacy of FTY720 in a rat model of NK-cell leukemia, Blood, vol.118, pp.2793-2800, 2011.

A. Mangraviti, T. Raghavan, F. Volpin, D. Skuli, D. Gullotti et al., HIF-1-targeting acriflavine provides long term survival and radiological tumor response in brain cancer therapy

M. Zeisberg and E. G. Neilson, Biomarkers of epithelial-mesenchymal transitions, J. Clin. Investig, vol.119, pp.1429-1437, 2009.

M. Kim, F. Cui, and Y. Kim, Hydrogen peroxide promotes epithelial to mesenchymal transition and stemness in human malignant mesothelioma cells. Asian Pac, J. Cancer Prev, vol.14, pp.3625-3630, 2013.

F. Briand, J. Nader, S. Deshayes, M. Grégoire, and D. L. Pouliquen, Differential expression of Hif1a, growth factors and cytokines related to EMT in an experimental biocollection of rat preneoplastic mesothelial cell lines, Proceedings of the 8th International Meeting on Epithelial-Mesenchymal Transition, 2017.

, The Human Protein Atlas, p.31, 2020.

D. L. Pouliquen, B. Nawrocki-raby, J. Nader, S. Blandin, M. Robard et al., Evaluation of intracavitary administration of curcumin for the treatment of sarcomatoid mesothelioma, Oncotarget, vol.8, pp.57552-57573, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-01480303

A. Guazzelli, P. Meysami, E. Bakker, E. Bonanni, C. Demonacos et al., What can independent research for mesothelioma achieve to treat this orphan disease?, Exp. Opin. Investig. Drugs, vol.28, pp.719-732, 2019.

V. Panou, M. Vyberg, U. M. Weinreich, C. Meristoudis, U. G. Falkmer et al., The established and future biomarkers of malignant pleural mesothelioma, Cancer Treat. Rev, vol.41, pp.486-495, 2015.

A. Cristaudo, A. Bonotti, G. Guglielmi, P. Fallahi, and R. Foddis, Serum mesothelin and other biomarkers: What have we learned in the last decades?, J. Thorac. Dis, vol.10, pp.353-359, 2018.

H. Sudo, A. B. Tsuji, A. Sugyo, M. Abe, O. Hino et al., AHNAK is highly expressed and plays a key role in cell migration and invasion in mesothelioma, Int. J. Oncol, vol.44, pp.530-538, 2014.

S. Zhang, Q. Zhang, Q. Sun, J. Tang, J. Chen et al., Genome evolution analysis of recurrent testicular malignant mesothelioma by whole-genome sequencing, Cell Physiol. Biochem, vol.45, pp.163-174, 2018.

A. Fassina, R. Cappellesso, V. Guzzardo, L. Dalla-via, S. Piccolo et al., Epithelial-mesenchymal transition in malignant mesothelioma, Mod. Pathol, vol.25, pp.86-99, 2012.

S. Destek and V. O. Gul, S100A4 may be a good prognostic marker and a therapeutic target for colon cancer, J. Oncol, 2018.

A. Ziegler, F. Cerciello, C. Bigosch, D. Bausch-fluck, E. Felley-bosco et al., Proteomic surfaceome analysis of mesothelioma, Lung Cancer, vol.75, pp.189-196, 2012.

F. Mundt, H. J. Johansson, J. Forshed, S. Arslan, M. Metintas et al., Proteome screening of pleural effusions identifies galectin 1 as a diagnostic biomarker and highlights several prognostic biomarkers for malignant mesothelioma, Mol. Cell. Proteom, vol.13, pp.701-715, 2014.

F. Grosserueschkamp, T. Bracht, H. Diehl, C. Kuepper, M. Ahrens et al., Spatial and molecular resolution of diffuse malignant mesothelioma heterogeneity by integrating label-free FTIR imaging, laser capture microdissection and proteomics

R. White, E. Pulford, D. J. Elliot, L. A. Thurgood, and S. Klebe, Quantitative mass spectrometry to identify protein markers for diagnosis of malignant pleural mesothelioma, J. Proteom, vol.192, pp.374-382, 2019.

J. Creaney, I. M. Dick, J. S. Leon, and B. W. Robinson, A proteomic analysis of the malignant mesothelioma secretome using iTRAQ. Cancer Genom, vol.14, pp.103-118, 2017.

H. Yang, Y. Geng, P. Wang, Y. Zhou, H. Yang et al., Extracellular ATP promotes breast cancer invasion and Epithelial-Mesenchymal Transition via Hypoxia-inducible factor 2? signaling, Cancer Sci, vol.110, pp.2456-2470, 2019.

A. Pezzuto, G. Perrone, N. Orlando, F. Citarella, M. Ciccozzi et al., A close relationship between HIF-1? expression and bone metastases in advanced NSCLC, a retrospective analysis, Oncotarget, vol.10, pp.7071-7079, 2019.

H. Yoshimura, A. Otsuka, M. Michishita, M. Yamamoto, M. Ashizawa et al., Expression and roles of S100A4 in anaplastic cells of canine mammary carcinomas, Vet. Pathol, vol.56, pp.389-398, 2019.

E. Lukanidin and J. P. Sleeman, Buiding the niche: The role of the S100 proteins in metastatic growth, Semin. Cancer Biol, vol.22, pp.216-225, 2012.

M. Q. Mahmood, C. Ward, H. K. Muller, S. S. Sohal, and E. H. Walters, Epithelial mesenchymal transition (EMT) and non-small cell lung cancer (NSCLC): A mutual association with airway disease, vol.34, p.45, 2017.

D. Gradl, M. Kühl, and D. Wedlich, The Wnt/Wg signal transducer-catenin controls fibronectin expression, Mol. Cell. Biol, vol.19, pp.5576-5587, 1999.

D. J. Stewart, Wnt signaling pathway in non-small cell lung cancer, J. Natl. Cancer Inst, vol.106, p.356, 2014.

A. Pezzuto, F. Cappuzzo, M. D'arcangelo, M. Ciccozzi, L. Navarini et al., Prognostic value of p16 protein in patients with surgically treated non-small cell lung cancer; relationship with Ki-67 and PD-L1, Anticancer Res, vol.40, pp.983-990, 2020.

D. B. Chapel, R. Stewart, L. V. Furtado, A. N. Husain, T. Krausz et al., Tumor PD-L1 expression in malignant pleural and peritoneal mesothelioma by Dako PD-L1 22C3 pharmDx and Dako PD-L1 28-8 pharmDx assays, Hum. Pathol, vol.87, pp.11-17, 2019.

D. T. Arnold and N. A. Maskell, Biomarkers in mesothelioma, Ann. Clin. Biochem, vol.55, pp.49-58, 2018.

S. Hiratsuka, A. Watanabe, H. Aburatani, and Y. Maru, Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis, Nat. Cell Biol, vol.8, pp.1369-1375, 2006.

S. Hiratsuka, A. Watanabe, Y. Sakurai, S. Akashi-takamura, S. Ishibashi et al., The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase, Nat. Cell Biol, vol.10, pp.1349-1355, 2008.

D. Foell, H. Wittkowski, T. Vogl, and J. Roth, S100 proteins expressed in phagocytes: A novel group of damage-associated molecular pattern molecules, J. Leukoc. Biol, vol.81, pp.28-37, 2007.

F. Shabani, A. Farasat, M. Mahdavi, and N. Gheibi, Calprotectin (S100A8/S100A9): A key protein between inflammation and cancer, Inflamm. Res, vol.67, pp.801-812, 2018.

T. Leanderson, D. Liberg, and F. Ivars, S100A9 as a pharmacological target molecule in inflammation and cancer, Endocr. Metab. Immune Disord. Drug Targets, vol.15, pp.97-104, 2015.

P. Björk, E. Källberg, U. Wellmar, M. Riva, A. Olsson et al., Common interactions between S100A4 and S100A9 defined by a novel chemical probe, PLoS ONE, vol.8, 2013.

J. Markowitz and W. E. Carson, Review of S100A9 biology and its role in cancer, Biochim. Biophys. Acta, vol.1835, pp.100-109, 2013.

R. Hage-sleiman, S. Herveau, E. Matera, J. Laurier, and C. Dumontet, Silencing of Tubulin Binding Cofactor C modifies microtubule dynamics and cell cycle distribution and enhances sensitivity to gemcitabine in breast cancer cells, Mol. Cancer Ther, vol.10, pp.303-312, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00828515

S. A. Maxwell, E. M. Cherry, K. J. Bayless, and . Akt, 14-3-3 ?, and vimentin mediate a drug-resistant invasive phenotype in diffuse large B-cell lymphoma, Leuk. Lymphoma, vol.52, pp.849-864, 2011.

Q. Zhang, Z. Zhao, Y. Ma, H. Wang, J. Ma et al., Combined expression of S100A4 and annexin A2 predicts disease progression and overall survival in patients with urothelial carcinoma, Urol. Oncol, vol.32, pp.798-805, 2014.

B. Peng, C. Guo, H. Guan, S. Liu, and M. Sun, Annexin A5 as a potential marker in tumors, Clin. Chim. Acta, vol.427, pp.42-48, 2014.

C. Sun, A. Zhao, S. Ji, X. Han, Z. Sun et al., Expression of annexin A5 in serum and tumor tissue of patients with colon cancer and its clinical significance, World J. Gastroenterol, vol.23, pp.7168-7173, 2017.

X. Sun, S. Liu, J. Wang, B. Wei, C. Guo et al., Annexin A5 regulates hepatocarcinoma malignancy via CRKI/II-DOCK180-RAC1 integrin and MEK-ERK pathways, Cell Death Dis, vol.9, 2018.

J. Kim, A. Louhghalam, G. Lee, B. W. Schafer, D. Wirtz et al., Nuclear lamin A/C harnesses the perinuclear apical actin cables to protect nuclear morphology, Nat. Commun, 2017.

L. Zuo, H. Zhao, R. Yang, L. Wang, H. Ma et al., Lamin A/C might be involved in the EMT signaling pathway, Gene, vol.663, pp.51-64, 2018.

F. Taheri, B. Isbilir, G. Müller, J. W. Krieger, G. Chirico et al., Random motion of chromatin is influenced by lamin A interconnections, Biophys. J, vol.114, pp.2465-2472, 2018.

K. Contrepois, C. Coudereau, B. A. Benayoun, N. Schuler, P. Roux et al., Histone variant H2A.J accumulates in senescent cells and promotes inflammatory gene expression, Nat. Commun, vol.8, 2017.
URL : https://hal.archives-ouvertes.fr/cea-02143246

P. Workman, E. O. Aboagye, F. Balkwill, A. Balmain, G. Bruder et al., Guidelines for the welfare and use of animals in cancer research, Br. J. Cancer, vol.102, pp.1555-1577, 2010.

I. Valo, P. Raro, A. Boissard, A. Maarouf, P. Jézéquel et al., OLFM4 expression in ductal carcinoma in situ and in invasive breast cancer cohorts by a SWATH-based proteomic approach, Proteomics, 2019.
URL : https://hal.archives-ouvertes.fr/inserm-02281345